Logo Logo

Publications by Amillano, K.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 3.

Journal article

Prat, A.; Ortega, V.; Villagrasa, P.; Paré, L.; Galván, P.; Oliveira, M.; Nucíforo, P.; Lluch, A.; Morales, S.; Amillano, K.; Lopez, R.; Gonzalez, R.; Manso, L.; Martinez, J.; Llombart, A.; Peña, L. de la; Cosimo, S. di; Rubio, I. T.; Harbeck, N.; Baselga, J.; Cortés, J. (2017): Efficacy and gene expression results from SOLTI1007 NEOERIBULIN phase II clinical trial in HER2-negative early breast cancer. In: Cancer Research, Vol. 77

Prat, A.; Ortega, V.; Paré, L.; Galván, P.; Oliveira, M.; Nuciforo, P.; Lluch, A.; Morales, S.; Amillano, K.; Lopez, R.; González, R.; Manso, L.; Martínez, J.; Llombart, A.; Peña, L. de la; di Cosimo, S.; Rubio, I. T.; Harbeck, N.; Baselga, J.; Cortés, J. (2016): Efficacy and gene expression results from eribulin SOLTI1007 neoadjuvant study. In: Cancer Research, Vol. 76

Wuerstlein, R.; Prat, A.; Ortega, V; Pare, L.; Galvan, P.; Nuciforo, P.; Oliverira, M.; Amillano, K.; Lopez, R.; Lluch, A.; Morales, S.; Gonzales, R.; Manso, L.; Martinez, J.; Llombart, A.; Pena, L. de la; Di Cosimo, S.; Rubio, I; Baselga, J.; Cortes, J.; Harbeck, N. (2016): Efficacy and gene expression results from SOLTI1007, a phase II study evaluating neoadjuvant eribulin in hormone receptor (HR)-positive/HER2-negative breast cancer. In: Oncology Research and Treatment, Vol. 39: pp. 182-183

This list was generated on Wed Nov 20 07:22:59 2019 CET.